Dr Reddy's quarterly net up 2 per cent
In an interview to NDTV Profit, Saumitra Chaudhuri, Member of Planning Commission, said that the rupee’s fall is a combination of various factors like fiscal deficit and weak capital flows. “The RBI is trying to stabilise the rupee,” he added.
Drug firm Dr Reddy's Laboratories on Friday reported a 2.46 per cent increase in consolidated net profit to Rs 342.70 crore for the fourth quarter ended March 31, 2012, over the same period of previous fiscal.
The company had posted a net profit of Rs 334.47 crore during the same period of previous fiscal, the company said in a filing to the BSE.
Net income from sales and services of the company rose to Rs 2,658.45 crore for the fourth quarter, as compared to Rs 2,017.27 crore during the same period of previous fiscal.
For the year ended March 31, 2012, the company posted a net profit of Rs 1,426.21 crore, as against Rs 1,104 crore in 2010-11 fiscal.
The company's net income from sales and service for the year ended March 31, 2012 rose to Rs 9,673.74 crore, compared to Rs 7,469.28 crore in the previous fiscal.
The company's board, which met today, recommended a final dividend of Rs 13.75 (275 per cent) per equity share of Rs 5 each, for the financial year 2011-12.